What is DHA Laboratory?
DHA Laboratory operates as a specialized diagnostic entity with over 35 years of experience in identifying the underlying biochemical drivers of clinical symptoms. The company distinguishes itself by bridging the gap between complex laboratory analysis and actionable medical treatment plans, specifically targeting mental and emotional health conditions. By providing high-precision testing services to both private medical practitioners and individual patients, DHA Laboratory has established a reputation for reliability and clinical excellence. Their market position is defined by a commitment to personalized medicine, where diagnostic data is translated into tailored therapeutic interventions, ensuring that patients receive care that addresses the root cause of their health challenges rather than merely managing symptoms.
How much funding has DHA Laboratory raised?
DHA Laboratory has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in DHA Laboratory
PPP
Public-Private Partnership
What's next for DHA Laboratory?
With the recent influx of capital, DHA Laboratory is poised to accelerate its operational scaling and technological integration. The strategic roadmap likely involves upgrading laboratory automation to increase throughput while maintaining the high-quality standards that have defined their 35-year tenure. Furthermore, the company is expected to deepen its collaboration with medical practitioners, potentially expanding its diagnostic portfolio to include emerging biomarkers related to neurological and emotional health. As the firm transitions through this late-stage growth phase, the focus will remain on optimizing patient outcomes through data-driven insights and expanding its footprint in the private healthcare market, ensuring long-term sustainability and continued innovation in the diagnostic space.
See full DHA Laboratory company page
